Kraton produces and sells styrenic block copolymers and other engineered polymers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Ubiquiti Networks, Inc. develops technology platforms for high-capacity distributed Internet access, unified information technology, and next-generation consumer electronics for home and personal use.
Obalon is purportedly a medical device company that develops and commercializes medical devices to treat obese and overweight people by facilitating weight loss. The Company claims that its initial product offering is the Obalon
balloon system, a U.S. Food and Drug Administration ("FDA") approved swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients.
According to the law firm press release, Kobe Steel is one of Japan's largest steel manufacturers and a major supplier of aluminum and copper products.
According to the law firm press release, Credit Suisse is a multinational financial services holding company with one of its four primary divisions focused on investment banking. The Company is based in Switzerland with its principal U.S. offices in New York, New York.
According to the Complaint, Aqua Metals was purportedly formed to engage in the business of recycling lead through a novel process called "AquaRefining." The Company claims that it has focused its efforts on developing and testing the AquaRefining process, developing a business plan, raising working capital, and developing its initial lead acid battery, or LAB, recycling facility in the Tahoe Regional Industrial Center, in McCarran, Nevada.
According to the law firm press release, Qudian is a Chinese provider of online micro-lending credit products. The Complaint charges Qudian, certain of its officers and directors, and the underwriters (collectively, the "Defendants") of the IPO with violations of the Securities Act.
According to the law firm press release, Katanga, through its subsidiary, Kamoto Copper Company SA, engages in the copper and cobalt mining and related activities in the Democratic Republic of Congo. The Company is incorporated in Bermuda and its head office is located in Baar, Switzerland.
According to the law firm press release, this action arises from the merger between Towers and Willis (the "Merger"), which closed on January 4, 2016. The Complaint alleges that, in connection with the Merger, Defendants violated provisions of the Exchange Act by issuing false and misleading statements in proxy materials filed with the SEC. Prior to the Merger, Towers was a leading global consulting company that helped organizations improve performance through risk management, human resources, actuarial and investment services. Willis, which was based in London, was a multinational risk advisor, insurance brokerage, and reinsurance brokerage company.
Array is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. The Company's lead cancer drug binimetinib (MEK162) was evaluated in multiple trials and combinations, including a Phase 3 "NEMO" study versus dacarbazine in unresectable or metastatic NRAS-mutant melanoma patients.